A Multiphasic Absorption Model Best Characterizes Gastrointestinal Absorption of Divalproex Sodium Extended-Release Tablets
Authors:
- 1 August 2006
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 46 (8) , 952-957
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Absolute Bioavailability and Absorption Characteristics of Divalproex Sodium Extended‐Release Tablets in Healthy VolunteersThe Journal of Clinical Pharmacology, 2004
- Divalproex to Divalproex Extended Release ConversionClinical Drug Investigation, 2004
- Pharmacokinetic Strategies in Deciphering Atypical Drug Absorption ProfilesThe Journal of Clinical Pharmacology, 2003
- Variability of gastrointestinal transit in healthy women and men.Gut, 1996
- Scintigraphic evaluation of small bowel transit in healthy subjects: Inter- and intrasubject variabilityGastroenterology, 1994
- Effects of gender, age, and body mass index on gastrointestinal transit timesDigestive Diseases and Sciences, 1992
- Effects of administration route on valproate pharmacokinetics in the rabbitFundamental & Clinical Pharmacology, 1991
- Measurement of Gastrointestinal pH and Regional Transit Times in Normal ChildrenJournal of Pediatric Gastroenterology and Nutrition, 1990
- Transit of pharmaceutical dosage forms through the small intestine.Gut, 1986
- BIOAVAILABILITY OF VALPROATE AFTER GASTRIC AND DIRECT INTESTINAL ADMINISTRATION IN RATSClinical and Experimental Pharmacology and Physiology, 1982